A forgotten opioid has resurfaced as a lethal street drug

Published Date: 17 Sep 2025

Nitazenes—a class of highly potent synthetic opioids—are rapidly emerging as a major contributor to the overdose crisis, according to a Pain Medicine review published today by authors from Vanderbilt University Medical ...

Read Full News

Latest News

BP Med Promising as First to Modify Rare Leukodystrophy

In a phase 1/2 study, guanabenz was associated with a 67% lower risk of losing the ability to walk in children with vanishing white matter disease, a rare and devastating leukodystrophy.

Behavioral Economics May Aid Obesity Results in Primary Care

From financial incentives to ‘gamification’ of weight loss, researchers are testing ways to help patients lose weight and keep it off.

WHO chief urges clampdown on nicotine products aimed at kids

Sleek-looking disposable e-cigarettes and candy-flavored nicotine pouches are among a range of new products targeting young people and fueling a new wave of tobacco and nicotine addiction, the WHO warned Monday.

Unregulated and unsafe: Expert warns of risks in substance use reduction apps

In a commentary published by the Journal of the American Medical Association, researchers at Rutgers Health, Harvard University and the University of Pittsburgh discuss the impact of unregulated mobile health and generative ...

Detection is not prevention: Will drug testing drivers really make NZ roads safer?

The government's new mandate to carry out random oral-fluid roadside drug testing marks a milestone in New Zealand's road safety policy.

The shocking cost of inaction on alcohol in Australia

Alcohol-related diseases and injuries have the potential to cost the Australian health care system a staggering $68 billion over 60 years if nothing is done to stop the impact.

Todays Updates

8 Pulmonology Headlines You Missed in Q3 2026

8 Pulmonology Headlines You Missed in Q3 2026

Phase 3 PROPEL Trial to Test Imeroprubart in Generalized Myasthenia Gravis Marco Meglio

PROPEL will test imeroprubart, an investigational FcRn blocker, against placebo in adults with mild to severe generalized myasthenia gravis.

This Week on NeurologyLive® — October 5, 2026 Isabella Ciccone, MPH

Here's some of what is coming soon to NeurologyLive® this week.

Ecopipam Shows Early and Sustained Tic Reduction in New Pediatric Tourette Syndrome Analyses Louie Pasculli

New analyses from the D1AMOND clinical program found that 69.8% of participants achieved a clinically meaningful reduction in tic severity within 8 weeks of ecopipam treatment, while an interim 18-month analysis showed sustained improvement without new safety signals.

LRRK2 Inhibitor BIIB122 Fails to Slow Early-Stage Parkinson Disease Marco Meglio

Full results from the phase 2b LUMA showed that investigational BIIB122/DNL151 did not slow confirmed clinical worsening in early-stage Parkinson's disease compared with placebo.

Phase 1 Data Link ARV-102 LRRK2 Degradation to Oculomotor and CSF Biomarker Changes in Parkinson Disease Louie Pasculli

Early phase 1 findings showed that the PROTAC LRRK2 degrader ARV-102 was associated with improvements in saccadic hypometria and changes in CSF markers of endolysosomal function, neuroinflammation, synaptic integrity, and axonal guidance in participants with Parkinson disease.

6 Nephrology Headlines You Missed in September 2026

6 Nephrology Headlines You Missed in September 2026

Todays Updates

8 Pulmonology Headlines You Missed in Q3 2026

8 Pulmonology Headlines You Missed in Q3 2026

Phase 3 PROPEL Trial to Test Imeroprubart in Generalized Myasthenia Gravis Marco Meglio

PROPEL will test imeroprubart, an investigational FcRn blocker, against placebo in adults with mild to severe generalized myasthenia gravis.

This Week on NeurologyLive® — October 5, 2026 Isabella Ciccone, MPH

Here's some of what is coming soon to NeurologyLive® this week.

Ecopipam Shows Early and Sustained Tic Reduction in New Pediatric Tourette Syndrome Analyses Louie Pasculli

New analyses from the D1AMOND clinical program found that 69.8% of participants achieved a clinically meaningful reduction in tic severity within 8 weeks of ecopipam treatment, while an interim 18-month analysis showed sustained improvement without new safety signals.

LRRK2 Inhibitor BIIB122 Fails to Slow Early-Stage Parkinson Disease Marco Meglio

Full results from the phase 2b LUMA showed that investigational BIIB122/DNL151 did not slow confirmed clinical worsening in early-stage Parkinson's disease compared with placebo.

Phase 1 Data Link ARV-102 LRRK2 Degradation to Oculomotor and CSF Biomarker Changes in Parkinson Disease Louie Pasculli

Early phase 1 findings showed that the PROTAC LRRK2 degrader ARV-102 was associated with improvements in saccadic hypometria and changes in CSF markers of endolysosomal function, neuroinflammation, synaptic integrity, and axonal guidance in participants with Parkinson disease.

6 Nephrology Headlines You Missed in September 2026

6 Nephrology Headlines You Missed in September 2026

Latest News

In a phase 1/2 study, guanabenz was associated with a 67% lower risk of losing the ability to walk in children with vanishing white matter disease, a rare and devastating leukodystrophy.

From financial incentives to ‘gamification’ of weight loss, researchers are testing ways to help patients lose weight and keep it off.

Sleek-looking disposable e-cigarettes and candy-flavored nicotine pouches are among a range of new products targeting young people and fueling a new wave of tobacco and nicotine addiction, the WHO warned Monday.

In a commentary published by the Journal of the American Medical Association, researchers at Rutgers Health, Harvard University and the University of Pittsburgh discuss the impact of unregulated mobile health and generative ...

The government's new mandate to carry out random oral-fluid roadside drug testing marks a milestone in New Zealand's road safety policy.

Alcohol-related diseases and injuries have the potential to cost the Australian health care system a staggering $68 billion over 60 years if nothing is done to stop the impact.

News All Time

Taking prescription opioids for too long can be harmful. Here's how to cut back and stop

Opioids, such as oxycodone, morphine, codeine, tramadol and fentanyl, are commonly prescribed to manage pain. You might be given a prescription when experiencing pain, or after surgery or an injury.

Vaping might seem safer than smoking but your heart could tell a different story

You may have heard that vaping is the "safer" choice than smoking. But what if the very thing designed to protect your health also puts your heart at risk?

Proposed policy calls for reduced nicotine levels in cigarettes

The American Association for Cancer Research (AACR) has endorsed a federal policy that would make cigarettes far less addictive. The proposed policy by the Food and Drug Administration (FDA) sets a maximum nicotine product ...

The 'hard, slow work' of reducing overdose deaths is having an effect

Illicit drug overdoses and the deaths they cause are trending down this year, despite spikes in a handful of states, according to a Stateline analysis of data from the federal Centers for Disease Control and Prevention.

Vaping has slowed progress in cutting teen smoking in NZ—new study

Smoking rates among adults have declined in Aotearoa New Zealand over recent decades, from 18% smoking regularly in 2011/12 to 8% in 2023/24.

A path to safer painkillers: Using cryo-electron microscopy, scientists visualize how opioids engage key brain receptor

Scientists have known for decades that opioids relieve pain by binding to molecular switches in the brain called mu-opioid receptors. What they didn't know—until now—was exactly what happens next.

More than half of young adults in Australia admit to driving drunk the morning after a night out

The belief that "friends do it too" is a major factor in young adults drink-driving (driving drunk) the morning after a night out, according to a study of almost 300 Queenslanders.

People with a gambling disorder are more likely to die by suicide, research finds

Published in BJPsych Open, this is the first UK study to use routinely collected NHS data to identify factors that may predict suicide among people with gambling problems. Using anonymous health care records from Wales covering ...

Closer proximity to cannabis retail stores linked with more cannabis use but less drinking

A statewide study of more than 60,000 adult Oregonians shows that living near cannabis retail stores is associated with a greater tendency toward frequent cannabis use but a lower likelihood of heavy alcohol consumption.

Declining union membership could be making US working-classes less happy, more susceptible to drug overdoses

When fewer people belong to unions and unions have less power, the impact goes beyond wages and job security. Those changes can hurt public health and make people more unhappy.

Tobacco still top cancer killer, despite falling smoking rates

Tobacco remains the leading preventable cause of cancer death in the U.S., despite a dramatic decline in smoking, a new American Cancer Society report says.

Among youth who vape, study finds rise in daily use and difficulty quitting

Since 2019, overall rates of nicotine vaping have declined among U.S. youth, but those who continue to vape are showing signs of worsening addiction, according to new USC research.

More states eliminating insurance hurdles for opioid use disorder medications

A new study from Tulane University found that, over the past decade, more states have moved to make it easier for people with opioid use disorder to get potentially life-saving medication.

Heterosexist discrimination linked to alcohol use among LGBQ+ students of immigrant origin

Lesbian, gay, bisexual, and queer college students distressed by harassment targeting their sexuality are at a higher risk for alcohol use, especially if they are of immigrant origin. This is among the findings of a new study ...

Reward-related neurons drive risky decision-making differently in male and female rats

Some people with psychiatric conditions, including addiction and attention deficit hyperactivity disorder, struggle to control their urges or make decisions under uncertainty. In a collaboration between the University of ...

Maldives begins 'generational ban' on smoking

The Maldives began implementing a smoking ban Saturday on anyone born after January 2007, becoming the only nation with a generational prohibition on tobacco, the Health Ministry said.

Recommended News For You

Review looks at potential treatment targets in the tumor microenvironment.

Chiauranib Slows Platinum-Resistant Ovarian Cancer

In Advanced Myxoid Liposarcoma, Is Trabectedin Winning?

MCh in Gynecologic Oncology: Admission, Medical School, Fees, Qualifications Information

MRD Tied to PFS in Lymphoma Patients on Epcoritamab

When it comes to obesity-related cancers, where you shop for food matters

Stem Cell Transplant Associated With Better PFS in NKTCL

Recommended Articles For You

From Muscle Soreness to Improved Endurance: The Benefits of Monitoring Lactic Acid Levels  

Red Cell Deformability as a Target in Critical Illness 

Ex Vivo Engineered Hematopoietic Therapies for Functional Restoration of Blood-Cell Production 

Beyond the Surface: Understanding the Silent Menace of Abdominal Hematomas 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

PNH With Extravascular Hemolysis Approves Factor D Inhibitor.

2.

Breast Cancer Incidence Rises in Asian American Women

3.

FDA Approves Subcutaneous Isatuximab for MM Indications

4.

Healthcare in the Mix in President Biden's Farewell Address

5.

More nonsmokers are getting lung cancer: Oncologist explains why

1.

Aging of Bone-Marrow Immune Niches: Mechanisms, Clinical Impact, and Therapeutic Horizons

2.

AI in Cancer Diagnostics and Imaging Interpretation

3.

The Importance of Early Detection: How Genetics Play a Role in Leucocythemia Diagnosis 

4.

Gene Therapy for Hemophilia: A New Hope on the Horizon

5.

The Basics of M.C.V Normal Range for Better Health Management

1.

International Conference on Best Practices in Oncology, Cardiology and Critical Care

2.

International Conference on Innovations in Critical Care for Oncology and Cardiology

3.

International Symposium on Oncology, Cardiology and Critical Care Innovations

4.

International Conference on Cancer Nursing and Hematology Support

5.

International Conference on Clinical Medicine and Surgical Care

1.

Recognizing Symptoms of Vitamin B12 Deficiency

2.

Navigating the Complexities of Ph Negative ALL - Part II

3.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks

4.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III

5.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot